CorMedix Inc. (CRMD) › Cost of RevenueCorMedix Inc. (CRMD) — Cost of RevenueAnnual figures by period end, from SEC filings.2012-12-31: $02013-12-31: -$201.6K2014-12-31: -$445.8K2015-12-31: -$318.7K2016-12-31: $366.7K2017-12-31: $115.0K2018-12-31: $396.8K2019-12-31: $373.2K2020-12-31: $204.8K2021-12-31: $148.9K2022-12-31: $3.7K2024-12-31: $3.03M2025-12-31: $22.09M$22.09M2012-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$22.09M+628.0%2026-03-05From 2025-01-012024-12-31$3.03M—2026-03-05From 2024-01-012022-12-31$3.7K-97.5%2024-03-12From 2022-01-012021-12-31$148.9K-27.3%2023-03-30From 2021-01-012020-12-31$204.8K-45.1%2022-03-29From 2020-01-012019-12-31$373.2K-5.9%2021-03-30From 2019-01-012018-12-31$396.8K+245.1%2020-03-16From 2018-01-012017-12-31$115.0K-68.6%2019-05-29From 2017-01-012016-12-31$366.7K—2018-03-19From 2016-01-012015-12-31-$318.7K—2017-03-16From 2015-01-012014-12-31-$445.8K—2017-03-16From 2014-01-012013-12-31-$201.6K—2015-03-12From 2013-01-012012-12-31$0—2014-03-31From 2012-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)